Executive Compensation Practices in Pharma – Insight into Congressional Oversight

In an exchange which has now gone viral, freshman U.S. Representative Katie Porter (D-Calif.) questioned former Celgene CEO Mark Alles about his 2017 compensation structure last week. Rep. Porter, who is now famous for employing the use of a dry-erase whiteboard during witness questioning, serves on the House Committee on Oversight and Reform. Last week’s hearing was titled “Unsustainable Drug Prices: Testimony from CEOs,” and featured testimony from six pharmaceutical executives over two days....
By: Mintz - ML Strategies

Array